Generic Medicines at Scale: Jan Aushadhi's 16,900+ stores
In India, medicine costs make up nearly two-thirds of what families spend on healthcare. A 2022 study showed 69% of out-of-pocket spending goes toward buying medicines. So if we can reduce drug prices, we can make the biggest difference in lowering healthcare costs.
Jan Aushadhi: India's generic medicine revolution
The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has changed how Indians buy medicines, with 16,900+ stores already and plans for 25,000 by 2027. Jan Aushadhi drugs are 50-90% cheaper than branded versions, with strict quality testing.
The digital backbone of affordable medicines
e-Aushadhi: the supply-chain brain
Used in 23 states, it manages procurement, storage and distribution online, handling 1.5 million transactions daily and ₹1,500 crore worth of medicines, with real-time dashboards, stock tracking and quality checks.
Janaushadhi Sugam & Pharma Sahi Daam
Price-transparency tools: Sugam helps patients find stores and compare branded vs generic prices; Pharma Sahi Daam lets users check real-time prices and report overcharging.
ABDM: the digital prescription network
67 crore ABHA IDs and 236 connected health apps. Through UHI, doctors prescribe digitally and patients order via e-pharmacies; NHCX can process claims instantly. Linking Jan Aushadhi catalogues to UHI and NHCX could mean cashless OPD medicines delivered directly.
Quality & transparency through tech
Every batch tested and logged; future systems can use blockchain and QR codes for instant authenticity verification, ensuring subsidies reach the right people without leakage.
Opportunities for IT and HealthTech firms
Supply-chain digitization (AI-driven demand forecasting, IoT/cloud stock tracking); consumer apps (price-comparison APIs, alerts for cheaper generics); data and analytics (national dashboards combining e-Aushadhi, Pharma Sahi Daam and ABDM); claims automation (integrating with NHCX for cashless OPD); and RegTech (blockchain traceability, QR verification).
What needs work
Doctors' preference for branded drugs remains a hurdle; stock shortages and supply delays occur in some areas; low public awareness limits adoption; and last-mile digital systems need strengthening.
The next leap is digital. By combining e-Aushadhi, price apps and ABDM prescriptions, India can move toward cashless, transparent, universal access to medicines, the world's largest digital medicine network.